Department Stores
Compare Stocks
2 / 10Stock Comparison
M vs DDS
Revenue, margins, valuation, and 5-year total return — side by side.
Department Stores
M vs DDS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Department Stores | Department Stores |
| Market Cap | $5.35B | $6.67B |
| Revenue (TTM) | $22.62B | $6.56B |
| Net Income (TTM) | $642M | $571M |
| Gross Margin | 36.5% | 38.3% |
| Operating Margin | 4.6% | 10.5% |
| Forward P/E | 8.8x | 16.5x |
| Total Debt | $5.20B | $358M |
| Cash & Equiv. | $1.25B | $862M |
M vs DDS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Macy's, Inc. (M) | 100 | 311.6 | +211.6% |
| Dillard's, Inc. (DDS) | 100 | 1904.3 | +1804.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: M vs DDS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
M is the clearest fit if your priority is value and momentum.
- Lower P/E (8.8x vs 16.5x)
- +69.1% vs DDS's +67.0%
DDS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 1.15, yield 5.6%
- Rev growth -0.4%, EPS growth -1.0%, 3Y rev CAGR -2.1%
- 9.0% 10Y total return vs M's -24.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.4% revenue growth vs M's -1.7% | |
| Value | Lower P/E (8.8x vs 16.5x) | |
| Quality / Margins | 8.7% margin vs M's 2.8% | |
| Stability / Safety | Beta 1.15 vs M's 1.42, lower leverage | |
| Dividends | 5.6% yield, 12-year raise streak, vs M's 3.7% | |
| Momentum (1Y) | +69.1% vs DDS's +67.0% | |
| Efficiency (ROA) | 16.3% ROA vs M's 4.0%, ROIC 29.7% vs 8.7% |
M vs DDS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
M vs DDS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DDS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
M is the larger business by revenue, generating $22.6B annually — 3.4x DDS's $6.6B. DDS is the more profitable business, keeping 8.7% of every revenue dollar as net income compared to M's 2.8%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $22.6B | $6.6B |
| EBITDAEarnings before interest/tax | $1.9B | $868M |
| Net IncomeAfter-tax profit | $642M | $571M |
| Free Cash FlowCash after capex | $1.1B | $620M |
| Gross MarginGross profit ÷ Revenue | +36.5% | +38.3% |
| Operating MarginEBIT ÷ Revenue | +4.6% | +10.5% |
| Net MarginNet income ÷ Revenue | +2.8% | +8.7% |
| FCF MarginFCF ÷ Revenue | +4.7% | +9.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.1% | -3.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +51.2% | -3.1% |
Valuation Metrics
M leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 8.3x trailing earnings, M trades at a 46% valuation discount to DDS's 15.3x P/E. On an enterprise value basis, M's 4.8x EV/EBITDA is more attractive than DDS's 7.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $5.4B | $6.7B |
| Enterprise ValueMkt cap + debt − cash | $9.3B | $6.2B |
| Trailing P/EPrice ÷ TTM EPS | 8.31x | 15.35x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.81x | 16.49x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 4.84x | 7.10x |
| Price / SalesMarket cap ÷ Revenue | 0.24x | 1.02x |
| Price / BookPrice ÷ Book value/share | 1.10x | 3.71x |
| Price / FCFMarket cap ÷ FCF | 5.07x | 10.69x |
Profitability & Efficiency
DDS leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
DDS delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $14 for M. DDS carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to M's 1.07x. On the Piotroski fundamental quality scale (0–9), M scores 7/9 vs DDS's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +14.2% | +24.3% |
| ROA (TTM)Return on assets | +4.0% | +16.3% |
| ROICReturn on invested capital | +8.7% | +29.7% |
| ROCEReturn on capital employed | +8.7% | +26.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 1.07x | 0.15x |
| Net DebtTotal debt minus cash | $4.0B | -$504M |
| Cash & Equiv.Liquid assets | $1.2B | $862M |
| Total DebtShort + long-term debt | $5.2B | $358M |
| Interest CoverageEBIT ÷ Interest expense | 10.62x | — |
Total Returns (Dividends Reinvested)
DDS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DDS five years ago would be worth $63,939 today (with dividends reinvested), compared to $12,916 for M. Over the past 12 months, M leads with a +69.1% total return vs DDS's +67.0%. The 3-year compound annual growth rate (CAGR) favors DDS at 29.0% vs M's 11.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.4% | -12.2% |
| 1-Year ReturnPast 12 months | +69.1% | +67.0% |
| 3-Year ReturnCumulative with dividends | +39.2% | +114.6% |
| 5-Year ReturnCumulative with dividends | +29.2% | +539.4% |
| 10-Year ReturnCumulative with dividends | -24.7% | +899.7% |
| CAGR (3Y)Annualised 3-year return | +11.7% | +29.0% |
Risk & Volatility
Evenly matched — M and DDS each lead in 1 of 2 comparable metrics.
Risk & Volatility
DDS is the less volatile stock with a 1.15 beta — it tends to amplify market swings less than M's 1.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. M currently trades 79.0% from its 52-week high vs DDS's 75.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.42x | 1.15x |
| 52-Week HighHighest price in past year | $24.41 | $741.98 |
| 52-Week LowLowest price in past year | $10.54 | $343.12 |
| % of 52W HighCurrent price vs 52-week peak | +79.0% | +75.4% |
| RSI (14)Momentum oscillator 0–100 | 47.6 | 35.2 |
| Avg Volume (50D)Average daily shares traded | 6.7M | 106K |
Analyst Outlook
DDS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates M as "Hold" and DDS as "Hold". Consensus price targets imply -0.4% upside for M (target: $19) vs -0.8% for DDS (target: $555). For income investors, DDS offers the higher dividend yield at 5.56% vs M's 3.70%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $19.20 | $555.00 |
| # AnalystsCovering analysts | 40 | 13 |
| Dividend YieldAnnual dividend ÷ price | +3.7% | +5.6% |
| Dividend StreakConsecutive years of raises | 4 | 12 |
| Dividend / ShareAnnual DPS | $0.71 | $31.08 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.7% | 0.0% |
DDS leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). M leads in 1 (Valuation Metrics). 1 tied.
M vs DDS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is M or DDS a better buy right now?
For growth investors, Dillard's, Inc.
(DDS) is the stronger pick with -0. 4% revenue growth year-over-year, versus -1. 7% for Macy's, Inc. (M). Macy's, Inc. (M) offers the better valuation at 8. 3x trailing P/E (8. 8x forward), making it the more compelling value choice. Analysts rate Macy's, Inc. (M) a "Hold" — based on 40 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — M or DDS?
On trailing P/E, Macy's, Inc.
(M) is the cheapest at 8. 3x versus Dillard's, Inc. at 15. 3x. On forward P/E, Macy's, Inc. is actually cheaper at 8. 8x.
03Which is the better long-term investment — M or DDS?
Over the past 5 years, Dillard's, Inc.
(DDS) delivered a total return of +539. 4%, compared to +29. 2% for Macy's, Inc. (M). Over 10 years, the gap is even starker: DDS returned +899. 7% versus M's -24. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — M or DDS?
By beta (market sensitivity over 5 years), Dillard's, Inc.
(DDS) is the lower-risk stock at 1. 15β versus Macy's, Inc. 's 1. 42β — meaning M is approximately 24% more volatile than DDS relative to the S&P 500. On balance sheet safety, Dillard's, Inc. (DDS) carries a lower debt/equity ratio of 15% versus 107% for Macy's, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — M or DDS?
By revenue growth (latest reported year), Dillard's, Inc.
(DDS) is pulling ahead at -0. 4% versus -1. 7% for Macy's, Inc. (M). On earnings-per-share growth, the picture is similar: Macy's, Inc. grew EPS 12. 1% year-over-year, compared to -1. 0% for Dillard's, Inc.. Over a 3-year CAGR, DDS leads at -2. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — M or DDS?
Dillard's, Inc.
(DDS) is the more profitable company, earning 8. 7% net margin versus 2. 8% for Macy's, Inc. — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DDS leads at 10. 5% versus 4. 6% for M. At the gross margin level — before operating expenses — DDS leads at 37. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is M or DDS more undervalued right now?
On forward earnings alone, Macy's, Inc.
(M) trades at 8. 8x forward P/E versus 16. 5x for Dillard's, Inc. — 7. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for M: -0. 4% to $19. 20.
08Which pays a better dividend — M or DDS?
All stocks in this comparison pay dividends.
Dillard's, Inc. (DDS) offers the highest yield at 5. 6%, versus 3. 7% for Macy's, Inc. (M).
09Is M or DDS better for a retirement portfolio?
For long-horizon retirement investors, Dillard's, Inc.
(DDS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 5. 6% yield, +899. 7% 10Y return). Both have compounded well over 10 years (DDS: +899. 7%, M: -24. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between M and DDS?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.